BONUSCAP-ZERTIFIKAT - BIOGEN IDEC | Market Closed - BOERSE MUENCHEN 01:16:59 29/06/2024 am IST | ||
| 316.7 EUR | +0.08% |
|
| Current month | +2.87% | ||
| 1 month | +6.50% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 316.7 | +0.08% |
| 27/24/27 | 316.4 | +1.85% |
| 26/24/26 | 310.6 | +0.45% |
| 25/24/25 | 309.2 | -1.22% |
| 24/24/24 | 313 | +1.21% |
Real-time BOERSE MUENCHEN
Last update June 29, 2024 at 01:16 am IST
More quotesStatic data
| Product type | Certificats Bonus |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HC8B8D |
| ISIN | DE000HC8B8D3 |
| Date issued | 28/07/2023 |
| Strike | 340 $ |
| Maturity | 20/12/2024 (173 Days) |
| Parity | 1 : 1 |
| Emission price | 290.6 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 318.2 € |
|---|---|
| Lowest since issue | 222.6 € |
| Spread | 0.09 € |
| Spread % | 0.03% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
231.8
USD
Average target price
283.2
USD
Spread / Average Target
+22.14%
- Stock Market
- Certificates
- Certificat
